World Heart Corporation is a worldwide pioneer and technology leader in heart assist therapy for end stage congestive heart failure. WorldHeart develops, manufactures and markets implantable heart assist devices that deliver pulsatile and rotary blood flow for temporary and long-term support to patients around the globe.

More than 1,700 patients with life-threatening heart failure have been supported by our leading Novacor® LVAS. As both temporary (Bridge-to-Transplant) and long-term support, the Novacor® LVAS increases our recipient's chance of survival and enables them to return to their families, homes, and hobbies.

THAT'S WORLDHEART... TECHNOLOGY for LIFE